APUS Stock Analysis: Buy, Sell, or Hold?

APUS - Apimeds Pharmaceuticals US, Inc.

PHARMACEUTICAL PREPARATIONS
$1.71
-0.07 (-3.93%) ▼
5d: -3.39%
30d: +2.7%
90d: -21.92%
BUY
HIGH Confidence
Last Updated: February 3, 2026

Get Alerted When APUS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: APUS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.

In-depth Analysis How we analyze

Valuation Analysis: APUS is currently trading at $1.71, which is considered fair relative to its 30-day fair value range of $1.63 to $1.91.

Technical Outlook: Technically, APUS is showing sideways momentum. Immediate support is located at $1.55, while resistance sits at $3.00. Short-term momentum is weak, with the stock down 3.9% recently.

Market Sentiment: APUS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Fair Price Range $1.63 - $1.91
Company Quality Score 48/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 79.4%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-3.9%)

Fair Price Analysis

30-Day Fair Range $1.63 - $1.91
Current vs Fair Value FAIR

Support & Resistance Levels

Support Level $1.55
Resistance Level $3.00
Current Trend Sideways

Fundamental Context

Last updated: February 04, 2026 3:43 AM ET
Data refreshes hourly during market hours. Next update: 4:43 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences I…
STRONG BUY
25 analysts
$180 65 BUY
ZTS
Zoetis Inc
STRONG BUY
19 analysts
$154 58 HOLD
LNTH
Lantheus Holdings Inc
STRONG BUY
13 analysts
$83 57 HOLD
BCRX
BioCryst Pharmaceuticals…
STRONG BUY
12 analysts
$22 57 HOLD
TEVA
Teva Pharma Industries L…
STRONG BUY
11 analysts
$37 59 HOLD

More Analysis for APUS

APUS Technical Chart APUS Price Prediction APUS Investment Advisor APUS Fair Price Analyzer APUS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals